...
首页> 外文期刊>Discover >Bionic Blood Sugar Control
【24h】

Bionic Blood Sugar Control

机译:仿生血糖控制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

For 14 years, ever since his son was an infant, Edward Damiano has worriedly checked on David as he slept. David has Type 1 diabetes and cannot regulate his blood sugar. His pancreas fails to produce and release two hormones: insulin, which lowers glucose levels in blood, and glucagon, which pushes glucose back up again. Despite insulin injections and regular monitoring, diabetics are whipsawed between extremes: High blood sugar degrades their organs over the years, while low blood sugar at any time can be fatal. Damiano feared that David could die of severe hypoglycemia in his sleep, what parents of diabetic children sometimes call "dead in bed syndrome." An associate professor of biomedical engineering, Damiano was in a position to help his son. "Years ago," he says, "I started thinking about a two-hormone system that would make automatic therapeutic decisions."
机译:自从儿子还是婴儿开始的14年里,爱德华·达米亚诺(Edward Damiano)在睡觉时一直担心检查大卫。大卫患有1型糖尿病,无法调节血糖。他的胰腺无法产生和释放两种激素:胰岛素可降低血液中的葡萄糖水平,而胰高血糖素可将葡萄糖再次升高。尽管注射了胰岛素并进行了定期监测,但糖尿病患者却被鞭打在极端之间:多年来,高血糖会降解其器官,而任何时候的低血糖都可能致命。达米亚诺担心戴维会在睡眠中死于严重的低血糖症,这是糖尿病儿童父母有时所说的“卧床综合症”。生物医学工程学副教授达米亚诺(Damiano)可以帮助他的儿子。他说:“几年前,我开始考虑一种可以自动做出治疗决定的两激素系统。”

著录项

  • 来源
    《Discover》 |2015年第1期|38-38|共1页
  • 作者

    JEFF WHEELWRIGHT;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号